Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alnylam pharmaceuticals
3
×
boston
3
×
boston blog main
boston top stories
life sciences
national blog main
national top stories
fda
harvard pilgrim health care
hereditary transthyretin amyloidosis
institute for clinical and economic review
new york blog main
patisiran
rna interference
akcea therapeutics
alexion pharmaceuticals
amy schulman
andreas klein
anna greka
barry greene
biotech
boehringer ingelheim
car-t
caron jacobson
cigall kadoch
clinical trials
craig mello
dan ollendorf
deals
dicerna pharamceuticals
drugs
european medicines agency
events
foghorn therapeutics
gene therapy
goldfinch biopharma
hepatitis b
hepatitis b virus
inotersen
luxturna
What
gene
3
×
drug
interference
medicines
protein
rna
alnylam
approves
aren’t
car
caught
causing
cells
cutting
dicerna
disease
edge
ema
employ
europe
experiments
eye
fda
follows
harmful
hepatitis
hits
hot
intended
launch
make
market
medicine
method
mute
pay
payers
pharma
pharmaceuticals
photos
Language
unset
Current search:
gene
×
boston
×
" alnylam pharmaceuticals "
×
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
@xconomy.com
5 years ago
CAR-T’s Launch, Payers vs. Gene Therapy & Photos From “What’s Hot”
